Editorial Policy
Alongside our catalogue, we publish clinical guidance, regulatory detail, and educational material covering the professional injectables and medical products we supply in Canada – from dermal fillers and HA fillers to biostimulators, skinboosters and orthopedic injections. Each is documented with current information on its regulatory standing, how it is used, its clinical context, and the manufacturer’s own specifications.
A large share of what we publish – across product pages, brand pages, category pages, and the blog – carries clinical claims, points to regulatory guidance, or lists specifications that practitioners weigh up before they buy. Because of that, this material moves through a defined editorial workflow built to keep quality high.
What follows explains how we create, check, and maintain that content, and the measures we take so it stays accurate, transparent, and appropriate for a website operating in the medical field.
Who this content is for
Kinami Health supplies licensed medical and aesthetic professionals – physicians, nurses, and clinics authorised to perform injectable and related procedures. Everything we write assumes that reader and the professional setting these products are used in. Our products are intended for professional use only and must be administered by a trained professional. We do not produce material designed to guide the personal health decisions of the general public. Clinical information sits within the frame of professional use, stays consistent with each product’s intended purpose and regulatory status, and carries a suitable note wherever it appears.What this policy covers
The standards below govern all substantive written content on the site, namely:- Product pages
- Brand and manufacturer pages
- Category pages
- Blog articles, clinical guides, and educational material
- Any page carrying clinical claims, regulatory detail, dosage references, or product specifications
The people behind our content
Our pages are produced by a team specialised in medical and aesthetic subject matter, with experience in scientific communication and the documentation of regulated products. We bring writers on board for one core skill: the ability to read scientific literature correctly, apply regulatory guidance, and write precisely for a professional medical readership. Before anyone starts writing, they receive a brief. It sets the topic, the clinical scope, the kinds of sources that are acceptable, the internal links to other parts of the site, and any wording constraints tied to the product category – including the line we hold between prescription medicines and medical devices. Content is not published under individual bylines. Writer qualifications are confirmed internally when they join us. You can read more about the team on our Editorial Team page.From brief to publication
Each page or article travels through the same five stages before it is live.Step 1 – Defining the brief
The team writes a working brief for the piece. It names the clinical subject, identifies the reader as a licensed professional, lists the claims that need addressing, sets out which source types are acceptable, and maps the links to related pages.Step 2 – Sourcing and writing
The writer works from peer-reviewed studies, official regulatory records, and manufacturer specifications, noting each source as the draft takes shape rather than bolting references on at the end.Step 3 – Checking every citation
Any statement resting on clinical data, a regulatory approval, or a product specification has to carry a source, and that source is checked against the original document. Databases such as PubMed and Google Scholar help locate the material, while the underlying evidence comes from peer-reviewed journals, official regulatory records, and manufacturer documentation. Where it adds useful context, we also draw on guidance from recognised professional bodies in aesthetic and orthopaedic medicine. Anything paraphrased is compared back to the original wording.Step 4 – Review and fact-check
An editor goes through every draft before it publishes, confirming that:- Each clinical claim is genuinely supported by the source cited
- Statements about regulatory status match the current position
- Product specifications line up with the manufacturer’s documentation
- The writing meets the precision a professional medical reader expects
- No claim reaches further than the evidence allows
- Prescription medicines and medical devices are each described within their correct regulatory frame
Step 5 – Going live
Publication happens only once every editorial point has been resolved. Where it applies, the publish date and any later update date are logged and shown on blog articles and clinical guides.How we evaluate sources
When we weigh evidence for a clinical or regulatory claim, we rank sources in the following order.Primary sources – our first choice
Peer-reviewed articles indexed in PubMed or comparable databases, systematic reviews and meta-analyses, and clinical trial registries.Regulatory records
Approved product information, Summaries of Product Characteristics, instructions for use, CE-marking documentation, and public assessment reports issued by the relevant competent authorities.Manufacturer documentation
Datasheets, instructions for use, and technical specifications from the company that makes the product.Secondary sources – context only
Guidelines from recognised professional bodies. We use these to frame and contextualise a point, not as the sole basis for a primary clinical statement.Clinical and regulatory accuracy
We sell only to licensed medical and aesthetic professionals, and everything we write assumes that reader and the professional setting these products are used in. Clinical information stays consistent with each product’s intended purpose and regulatory status, and carries a suitable note wherever it appears. Where a product carries CE marking, we describe it on that basis; we do not import approval claims from other jurisdictions as though they applied in Europe. Because we operate across several markets, a product’s regulatory standing can differ from one country to another. We say so where it matters, we describe products in accordance with applicable regulations rather than naming a single national authority, and we never present an unapproved use as though it were approved. Prescription medicines and medical devices are kept clearly distinct in how we describe them.Keeping content current
We review what we have published on an ongoing basis. A review is triggered when:- A product’s regulatory status or product information changes
- Notable new clinical evidence lands that bears on a claim already on the page
- A manufacturer revises a specification or an instructions-for-use document
- Someone reports a possible error through the process below
- A scheduled check comes due, which we run more often on high-traffic pages